From the reviews: "This book is designed as an accessible, up-to date reference for clinicians using antiplatelet and anticoagulation therapy. The intended audience is the 'busy clinician,' but clearly the book is meant for those with regular exposure to patients with cardiovascular disease, acute coronary syndromes, and thromboembolic disease including emergency physicians, cardiologists, and primary care physicians. ... This book coincides with a relative explosion of new therapeutic options of antiplatelets and anticoagulants and is a useful addition to the literature." (Don Allen Davis, Doody's Book Reviews, May, 2013)

• Antiplatelet agents: current and novel.- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring.- Anticoagulant Drugs: Current and Novel.- Primary prevention of cardiovascular disease.- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease.

From the reviews: "This book is designed as an accessible, up-to date reference for clinicians using antiplatelet and anticoagulation therapy. The intended audience is the 'busy clinician,' but clearly the book is meant for those with regular exposure to patients with cardiovascular disease, acute coronary syndromes, and thromboembolic disease including emergency physicians, cardiologists, and primary care physicians. ... This book coincides with a relative explosion of new therapeutic options of antiplatelets and anticoagulants and is a useful addition to the literature." (Don Allen Davis, Doody's Book Reviews, May, 2013)

• Antiplatelet agents: current and novel.- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring.- Anticoagulant Drugs: Current and Novel.- Primary prevention of cardiovascular disease.- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease.

From the reviews: "This book is designed as an accessible, up-to date reference for clinicians using antiplatelet and anticoagulation therapy. The intended audience is the 'busy clinician,' but clearly the book is meant for those with regular exposure to patients with cardiovascular disease, acute coronary syndromes, and thromboembolic disease including emergency physicians, cardiologists, and primary care physicians. ... This book coincides with a relative explosion of new therapeutic options of antiplatelets and anticoagulants and is a useful addition to the literature." (Don Allen Davis, Doody's Book Reviews, May, 2013)

• Antiplatelet agents: current and novel.- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring.- Anticoagulant Drugs: Current and Novel.- Primary prevention of cardiovascular disease.- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease.